Secondary Offering for MYnd Analytics

(Est. Date 07/14/2017)

MYnd Analytics is a predictive analytics company that develops decision support tools to guide personalize treatment of behavioral disorders, including depression, anxiety, bipolar disorder, and PTSD. MYnd Analytics's Psychiatric Electroencephalography Evaluation Registry (PEER) is a cloud-based platform that allows physicians to exchange outcome data referenced to their patients' neurophysiology. PEER Online is a service that allows physicians to compare and learn which medication treatments have been effective, and which have not been effective for their peers treating patients with similar brain patterns. It builds on the company's original physician-developed database, Referenced-EEG® (rEEG®). As a cloud-based outcome registry, PEER Online provides the same kind of vital exchange of information between medical professionals treating patients with mental health issues.

One share of common stock is being sold together with a warrant, with each warrant being immediately exercisable for one share of common stock at an exercise price of 100% of the price for each share sold in this offering, subject to adjustments as described herein, and expiring five years after the issuance date.

Show More
This information has been gathered from the company's offering prospectus.

Secondary Offering Documentation

Loading...

Key Secondary Offering Data

MYND
NASDAQ
$9,000,000
1,385,000
Maxim Group LLC
This information has been gathered from the company's offering prospectus.

How Does a Secondary Offering Work?

Open a Motif Account

Open a brokerage account to get ready for trading.

Participate in an Offering

Review secondary offering pricing, prospectus, and other documentation.

Place a Conditional Order

Select an investment amount and fund the secondary offering.

Receive Your Offering Shares

View your allocated shares on account positions page.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to notice of its acceptance given after the effective date.